{"entity":{"type":"insider","cik":"0002000284","url":"/insider/0002000284","json_url":"/insider/0002000284.json","name":"Kurtoglu Metin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":4,"first":"2024-11-18","last":"2025-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Kurtoglu Metin","source":"filing","n_filings":4,"first_seen":"2024-11-18","last_seen":"2025-01-07"}],"transactions":[{"id":4362973,"accession":"0001453687-25-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001453687-25-000040","line_url":"/filing/0001453687-25-000040#line-2","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2458.0,"shares_display":"2,458","price_per_share":16.8322,"price_display":"16.83","price_state":"stated","total_value":41373.5476,"total_display":"41,373.55","total_whole":"41,374","shares_owned_after":62258.0,"shares_owned_after_display":"62,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":4362970,"accession":"0001453687-25-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001453687-25-000040","line_url":"/filing/0001453687-25-000040#line-1","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2417.0,"shares_display":"2,417","price_per_share":16.7219,"price_display":"16.72","price_state":"stated","total_value":40416.8323,"total_display":"40,416.83","total_whole":"40,417","shares_owned_after":64716.0,"shares_owned_after_display":"64,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":3204923,"accession":"0001453687-24-000145","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001453687-24-000145","line_url":"/filing/0001453687-24-000145#line-5","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2901.0,"shares_display":"2,901","price_per_share":24.3503,"price_display":"24.35","price_state":"stated","total_value":70640.2203,"total_display":"70,640.22","total_whole":"70,640","shares_owned_after":51033.0,"shares_owned_after_display":"51,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider"},{"id":3204918,"accession":"0001453687-24-000145","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001453687-24-000145","line_url":"/filing/0001453687-24-000145","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10763.0,"shares_display":"10,763","price_per_share":25.503450552819846,"price_display":"25.50","price_state":"stated","total_value":274493.6383,"total_display":"274,493.64","total_whole":"274,494","shares_owned_after":55572.0,"shares_owned_after_display":"55,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-11","scope":"insider","n_lines":2},{"id":2282017,"accession":"0001453687-24-000140","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001453687-24-000140","line_url":"/filing/0001453687-24-000140#line-7","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32789.0,"shares_display":"32,789","price_per_share":16.669,"price_display":"16.67","price_state":"stated","total_value":546559.841,"total_display":"546,559.84","total_whole":"546,560","shares_owned_after":51033.0,"shares_owned_after_display":"51,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-21","scope":"insider"},{"id":2282009,"accession":"0001453687-24-000140","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001453687-24-000140","line_url":"/filing/0001453687-24-000140","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":17.292933333333334,"price_display":"17.29","price_state":"stated","total_value":98569.72,"total_display":"98,569.72","total_whole":"98,570","shares_owned_after":51133.0,"shares_owned_after_display":"51,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-21","scope":"insider","n_lines":2},{"id":2282001,"accession":"0001453687-24-000140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001453687-24-000140","line_url":"/filing/0001453687-24-000140#line-2","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":3900.0,"total_display":"3,900.00","total_whole":"3,900","shares_owned_after":51033.0,"shares_owned_after_display":"51,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-21","scope":"insider"},{"id":2111738,"accession":"0001453687-24-000132","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001453687-24-000132","line_url":"/filing/0001453687-24-000132","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34400.0,"shares_display":"34,400","price_per_share":18.390720465116278,"price_display":"18.39","price_state":"stated","total_value":632640.784,"total_display":"632,640.78","total_whole":"632,641","shares_owned_after":51033.0,"shares_owned_after_display":"51,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-18","scope":"insider","n_lines":2},{"id":2111729,"accession":"0001453687-24-000132","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001453687-24-000132","line_url":"/filing/0001453687-24-000132#line-5","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22068.0,"shares_display":"22,068","price_per_share":17.1967,"price_display":"17.20","price_state":"stated","total_value":379496.7756,"total_display":"379,496.78","total_whole":"379,497","shares_owned_after":51033.0,"shares_owned_after_display":"51,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-18","scope":"insider"},{"id":2111722,"accession":"0001453687-24-000132","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001453687-24-000132","line_url":"/filing/0001453687-24-000132","is_derivative":false,"issuer_cik":"0001453687","issuer_name":"Cartesian Therapeutics, Inc.","issuer_ticker":"RNAC","issuer_name_source":null,"issuer_url":"/issuer/0001453687","owner_cik":"0002000284","owner_name":"Kurtoglu Metin","owner_display_name":"Kurtoglu Metin","owner_url":"/insider/0002000284","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25900.0,"shares_display":"25,900","price_per_share":16.444020077220078,"price_display":"16.44","price_state":"stated","total_value":425900.12,"total_display":"425,900.12","total_whole":"425,900","shares_owned_after":55033.0,"shares_owned_after_display":"55,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-14","filed_date":"2024-11-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001453687","name":"Cartesian Therapeutics, Inc.","url":"/issuer/0001453687","role":"Officer (Chief Technology Officer)","n_filings":4,"first_seen":"2024-11-18","last_seen":"2025-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002000284","retrieved_at":"2026-08-24T02:22:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}